Tweets
FDA approved 1st drug for kids with COVID-19. Veklury (remdesivir) get an expanded indication in Peds >28days old & wt > 3 kg who has SARS-CoV-2 & are Hospitalized, or Not hospitalized & at high risk for severe COVID-19 or death https://t.co/7Hn4CwKjxv
Links:
Dr. John Cush @RheumNow ( View Tweet )
4 years 3 months ago
COVID-19 Vaccination Uptake and Perceptions in Rheumatic Patients
Putman et al has reported vaccine survey results from the C19-GRA in Lancet Rheumatology showing the uptake and vaccine hesitancy among people with rheumatic diseases (RMD).
https://t.co/sqsOHGThzV https://t.co/zeZrlDeQ9Z
Links:
Dr. John Cush @RheumNow ( View Tweet )
4 years 3 months ago
One centers experience with a combined Rheum-Derm Clinic. Among 151 psoriasis patients with suspicious musculoskeletal complaints, 85% were dx w/ PsA - 62% of these PsA was 1st diagnosed. https://t.co/RcQrWaXTWj
Links:
Dr. John Cush @RheumNow ( View Tweet )
4 years 3 months ago
QD Clinic - PsA lessons and cases from the Rheumatology clinic.
Distinguishing Psoriatic arthritis from Erosive Osteoarthritis can be difficult
https://t.co/UCcCMqUL2d https://t.co/zLkfBYI4Cm
Links:
Dr. John Cush @RheumNow ( View Tweet )
4 years 3 months ago
Open label, RCT compared triple DMARD Rx adding either LEF (MLH) or SSZ (MSH) to MTX+HCQ in 136 RA pts. Both were equally effective (non-inferior), 61.7% & 64.7% patients (p = 0.8) at wk 24. AE were also equal (15 vs 21 AE). https://t.co/ZucrYKuNms
Links:
Dr. John Cush @RheumNow ( View Tweet )
4 years 3 months ago
Mark your calendars for our next Tuesday Night Rheumatology on 4/26 at 7pm!
Speakers will include:
Dr. Eric Ruderman
Dr. Arthur Kavanaugh
Dr. David Liew
Dr. Jack Cush
https://t.co/by1xtmPSZ0
You can also find us LIVE on YouTube, Twitter, and Facebook. https://t.co/o633KHx81b
Links:
Dr. John Cush @RheumNow ( View Tweet )
4 years 3 months ago
ICYMI:Faith in Exercise Benefit Boosts Actual Benefit in SpA
https://t.co/kEErN5IZUI https://t.co/9ve0ey9MRp
Links:
Dr. John Cush @RheumNow ( View Tweet )
4 years 3 months ago
Global Rheumatology Therapeutics (drug) Market size is estimated to be $29.37 billion (USD) in 2022, and is projected to grow to $40.13 billion by 2027. https://t.co/JDzkYFENFc
Links:
Dr. John Cush @RheumNow ( View Tweet )
4 years 3 months ago
ICYMI: Axial Disease in Psoriatic Arthritis
Inflammatory involvement of the axial skeleton and sacroiliac joints occurs, on average, in 40-50% of patients with psoriatic arthritis (PsA).
https://t.co/QKtpSPDz5V https://t.co/ROz5o9OTyZ
Links:
Dr. John Cush @RheumNow ( View Tweet )
4 years 3 months ago
QD clinic - PsA Lessons from Patients
Enthesitis in a 14 yr.old - management and evolutionary possibilities
https://t.co/MtgoDXJ7EF https://t.co/sTFyySF4vl
Links:
Dr. John Cush @RheumNow ( View Tweet )
4 years 3 months ago
Did you missed this past Tuesday Night Rheumatology? We have the playback available now.
The PsA Expert panelists included: Dr. Dafna Gladman Dr. Joseph Merola, Dr. Peter Nash, Dr. Christopher Ritchlin, Dr. Jose Scher and Dr. Jack Cush.
https://t.co/u5lt2uDoGK https://t.co/lOmN4OoGLi
Links:
Dr. John Cush @RheumNow ( View Tweet )
4 years 3 months ago
COVID-19 Vaccination Uptake and Perceptions in Rheumatic Patients
Putman et al has reported vaccine survey results from the C19-GRA in Lancet Rheumatology showing the uptake and vaccine hesitancy among people with rheumatic diseases (RMD).
https://t.co/fIHAhpvVho https://t.co/6tFbQd0vJQ
Links:
Dr. John Cush @RheumNow ( View Tweet )
4 years 3 months ago
